Asthma Development Services
-
Manufactured by HAL Allergy Groupbased in NETHERLANDS
High prevalence rates illustrate the relevance of allergic research, An unmet need for novel targeted medicines that treat the underlying cause of allergic rhinitis and asthma still does exist. Until now allergen immunotherapy is the only disease modifying therapy tackling the cause of allergies. It even can reduce the risk of allergic ...
-
based in USA
Since the mid-1980s, asthma rates in the U.S. have skyrocketed to epidemic levels, particularly in young children. In the U.S. alone, around 16 million people suffer from asthma. Asthma is a serious chronic disorder, and in some cases life-threatening disease, of the lungs characterized by recurrent attacks of bronchial constriction, which ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you